VASCULITIS SYNDROMES RAVE about rituximab in ANCA vasculitis?

被引：1
|
作者：
Tarzi, Ruth [1 ]
Pusey, Charles [1 ]
机构：
[1] Hammersmith Hosp, Dept Med, Renal & Vasc Inflammat Sect, London W12 0NN, England
来源：
NATURE REVIEWS NEPHROLOGY | 2013年 / 9卷 / 11期
关键词：
ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; CYCLOPHOSPHAMIDE; REMISSION; INDUCTION; EFFICACY; THERAPY;
D O I：
10.1038/nrneph.2013.204
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Follow-up data from the RAVE trial have shown that rituximab is as effective as immunosuppression with cyclophosphamide followed by azathioprine in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. Rituximab is likely to become the standard of care for many patients with ANCA disease. However, an individualized approach is needed to identify those who require more-intense or prolonged therapy.
引用
收藏
页码：628 / 629
页数：2
相关论文
共 50 条
  • [31] Rituximab Treatment for Vasculitis
    Jayne, David
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08): : 1359 - 1362
  • [32] Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
    Bensalem, Amina
    Mulleman, Denis
    Paintaud, Gilles
    Azzopardi, Nicolas
    Gouilleux-Gruart, Valerie
    Cornec, Divi
    Specks, Ulrich
    Ternant, David
    CLINICAL PHARMACOKINETICS, 2020, 59 (04) : 519 - 530
  • [33] ANCA-ASSOCIATED VASCULITIS
    Vandergheynst, F.
    ACTA CLINICA BELGICA, 2013, 68 (06) : 406 - 410
  • [34] Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohort
    Chasseur, P.
    Blockmans, D.
    von Frenckell, C.
    Nicolas, J-B.
    Regniers, C.
    Vandergheynst, F.
    ACTA CLINICA BELGICA, 2020, 75 (03) : 163 - 169
  • [35] Treatment Strategies in ANCA-Associated Vasculitis
    Emejuaiwe, Nkechinyere
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (07)
  • [36] Damage Assessment in ANCA-Associated Vasculitis
    Bhamra, Kuljeet
    Luqmani, Raashid
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) : 494 - 500
  • [37] Renal Involvement in ANCA-associated vasculitis
    Kronbichler, Andreas
    Windpessl, Martin
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (02) : 141 - 149
  • [38] Advances in Therapy for ANCA-Associated Vasculitis
    Duvuru Geetha
    Philip Seo
    Current Rheumatology Reports, 2012, 14 : 509 - 515
  • [39] Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis
    Nagafuchi, Hiroko
    Atsumi, Tatsuya
    Hatta, Kazuhiro
    Muso, Eri
    Takeno, Mitsuhiro
    Yamada, Hidehiro
    Ozaki, Shoichi
    MODERN RHEUMATOLOGY, 2015, 25 (04) : 603 - 608
  • [40] Rituximab in ANCA-Associated Vasculitis: Fad or Fact?
    Fervenza, Fernando C.
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C182 - C188
12345